Evaluation of current and emerging endoluminal robotic platforms using the IDEAL framework
Minimally Invasive Therapy & Allied Technologies · 04.07.2025 · 34 (4) · 253-266
DOI: 10.1080/13645706.2025.2467805 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Minimally Invasive Therapy & Allied Technologies, online erschienen am 21.02.2025. Verfasst von Diya Shah und 4 weiteren Autor:innen. Beteiligte Einrichtung: University College London Medical School, London, UK. Hauptthemen laut MEDLINE: Robotic Surgical Procedures, Minimally Invasive Surgical Procedures. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
BACKGROUND: Robotic-assisted endoluminal systems are rapidly evolving within the field of minimally invasive surgery. The IDEAL framework (Idea, Development, Exploration, Assessment, and Surveillance) can be used to evaluate novel technologies. This review provides a summary of current and emerging endoluminal systems using the IDEAL framework. METHODS: A scoping review was conducted to include all existing and developing robotic-assisted endoluminal systems. Data was collected via virtual interviews, questionnaires, biomedical databases, company websites, and peer-reviewed articles. Key metrics were reported, enabling the assignment of each system to an IDEAL stage. RESULTS: The review identified 17 distinct systems from 16 companies. Nine systems received regulatory approval in their respective countries. Our evaluation showed that two systems were at the pre-IDEAL Stage 0. Seven systems were in the Idea stage (Stage 1), six systems were in the Development stage (Stage 2) and two systems completed Stage 3. No system underwent long-term study evaluation (Stage 4). CONCLUSIONS: There is a gap in long-term clinical data of robotic-assisted endoluminal systems, indicated by the absence of systems at Stage 4. Collaborative efforts amongst the medical community, regulatory bodies, and industry specialists are vital to ensure the delivery of evidence-based medicine in the discipline of robotics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- University College London Medical School, London, UK.
- The Griffin Institute, Northwick Park & St Marks' Hospital, London, UK.
- EGA Institute for Women's Health, University College London (UCL), London, UK.
- Wellcome/EPSRC Centre for Interventional and Surgical Sciences (WEISS), UCL, London, UK.
- Association of Laparoscopic Surgeons of Great Britain and Ireland (ALSGBI), London, UK.
- Department of Surgical Sciences, University of Torino, Turin, Italy.
ORCID-Profile: Diya Shah, Freweini Martha Tesfai, Alberto Arezzo
Zitieren
APA
Shah, D., Tesfai, F. M., Boal, M., Arezzo, A., & Francis, N. (2025). Evaluation of current and emerging endoluminal robotic platforms using the IDEAL framework. Minimally Invasive Therapy & Allied Technologies, 34(4), 253-266. https://doi.org/10.1080/13645706.2025.2467805
Vancouver
Shah D, Tesfai FM, Boal M, Arezzo A, Francis N. Evaluation of current and emerging endoluminal robotic platforms using the IDEAL framework. Minimally Invasive Therapy & Allied Technologies. 2025;34(4):253-266. doi:10.1080/13645706.2025.2467805
BibTeX
@article{Shah2025,
author = {Shah, Diya and Tesfai, Freweini Martha and Boal, Matthew and Arezzo, Alberto and Francis, Nader},
title = {Evaluation of current and emerging endoluminal robotic platforms using the IDEAL framework},
journal = {Minimally Invasive Therapy & Allied Technologies},
year = {2025},
volume = {34},
number = {4},
pages = {253--266},
doi = {10.1080/13645706.2025.2467805}
}
EUVIMED